A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers
Status:
Terminated
Trial end date:
2019-05-16
Target enrollment:
Participant gender:
Summary
This is a first in human study to determine the safety, tolerability, pharmacokinetics and
pharmacodynamics of ONO-5788 in healthy adult volunteers. This study will be conducted in 4
parts: a single-ascending dose part, a multiple-ascending dose part, an elderly part and a
proof of principle part.